**List of abbreviations**

treatment coverage, because higher immunity reduces the probability of developing symptoms and the proportion of infections getting treated. However, when transmission is high, the reduction in prevalence after an MDA is temporary, due to the drug half-life and imperfect coverage levels, and individuals are likely to become reinfected quickly, therefore in the

**Figure 4.** Simulated impact of increasing treatment coverage or mass drug administration (MDA) on the proportion of mosquitoes infected by a population: influence of transmission setting and infection duration. The grey lines represent

continuing 50% treatment coverage and no MDA, and the blue and red lines as shown in the legend.

140 Towards Malaria Elimination - A Leap Forward


